Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Two-Year Real-World Outcomes of Faricimab in Treatment-Resistant Neovascular Age-Related Macular Degeneration

Saved in:
Bibliographic Details
Published in:Clinical Ophthalmology
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867664056297455616
collection WordPress RSS
FRELIP Feed Integration
container_title Clinical Ophthalmology
description
discipline_display Ophthalmology and Optometry
discipline_facet Ophthalmology and Optometry
format Online Article
RSS Article
genre Journal Article
id rss_article:89587
institution FRELIP
journal_source_facet Clinical Ophthalmology
last_indexed 2026-06-11T02:00:41.891Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Two-Year Real-World Outcomes of Faricimab in Treatment-Resistant Neovascular Age-Related Macular Degeneration
Ophthalmology and Optometry
General
Ophthalmology and Optometry
sub_discipline_display General
sub_discipline_facet General
subject_display Ophthalmology and Optometry
General
Ophthalmology and Optometry
Ophthalmology and Optometry
General
Ophthalmology and Optometry
subject_facet Ophthalmology and Optometry
General
Ophthalmology and Optometry
title Two-Year Real-World Outcomes of Faricimab in Treatment-Resistant Neovascular Age-Related Macular Degeneration
title_auth Two-Year Real-World Outcomes of Faricimab in Treatment-Resistant Neovascular Age-Related Macular Degeneration
title_full Two-Year Real-World Outcomes of Faricimab in Treatment-Resistant Neovascular Age-Related Macular Degeneration
title_fullStr Two-Year Real-World Outcomes of Faricimab in Treatment-Resistant Neovascular Age-Related Macular Degeneration
title_full_unstemmed Two-Year Real-World Outcomes of Faricimab in Treatment-Resistant Neovascular Age-Related Macular Degeneration
title_short Two-Year Real-World Outcomes of Faricimab in Treatment-Resistant Neovascular Age-Related Macular Degeneration
title_sort two-year real-world outcomes of faricimab in treatment-resistant neovascular age-related macular degeneration
topic Ophthalmology and Optometry
General
Ophthalmology and Optometry
url https://www.dovepress.com/two-year-real-world-outcomes-of-faricimab-in-treatment-resistant-neova-peer-reviewed-fulltext-article-OPTH